Pharmacy alert: oral ranitidine formulations supply disruption
The Department of Health and Social Care (DHSC) has advised of a disruption to supply of all oral formulations of ranitidine until further notice. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 16, 2019 Category: Drugs & Pharmacology Source Type: news
Drug regulator steps up monitoring of ranitidine
The US FDA announced an update of testing of NDMA in ranitidine, warning manufacturers not to use a high-temperature test for NDMA as it generates high levels of the impurity. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 13, 2019 Category: Pharmaceuticals Source Type: news
Questions and Answers: NDMA Impurities in Ranitidine (Commonly Known as Zantac)
October 11, 2019
What patients should know about NDMA impurities in ranitidine
Not all ranitidine medicines marketed in the U.S. are being recalled.
FDA does not have scientific evidence to recommend whether individuals should continue or... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 11, 2019 Category: Pharmaceuticals Source Type: news
Questions and Answers: NDMA impurities in ranitidine (commonly known as Zantac)
Answers to questions about NDMA impurities found in ranitidine and FDA ’s actions to address the issue (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 11, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Zantac (ranitidine): Safety Information - NDMA Found in Samples of Some Ranitidine Medicines
FDA has learned that some ranitidine medicines, including some products commonly known as the brand-name drug Zantac, contain NDMA. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 11, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Prescribed Zantac heartburn medicine recall in UK
Doctors are being told stop prescribing four types of Zantac, also known as ranitidine, as a "precaution". (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 8, 2019 Category: Consumer Health News Source Type: news
Class 2 medicines recall: Zantac injection 50mg/2ml, Zantac syrup 150mg/10ml, Zantac tablets 150mg, Zantac tablets 300mg
GlaxoSmithKline, trading as Glaxo Welcome Ltd, is recalling all unexpired stock of Zantac (ranitidine hydrochloride) prescription only medicines (POM) from pharmacies. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 8, 2019 Category: Drugs & Pharmacology Source Type: news
